Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Pulmonx Corporation
Pulmonx Corporation News
Pulmonx Corporation Quantitative Score
About Pulmonx Corporation
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Pulmonx Corporation Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Pulmonx Corporation Financials
Table Compare
Compare LUNG metrics with: | |||
|---|---|---|---|
Earnings & Growth | LUNG | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | LUNG | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | LUNG | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | LUNG | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Pulmonx Corporation Income
Pulmonx Corporation Balance Sheet
Pulmonx Corporation Cash Flow
Pulmonx Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Pulmonx Corporation Executives
| Name | Role |
|---|---|
| Mr. Steven S. Williamson | Advisor |
| Mr. Mehul Joshi | Advisor |
| Mr. Glendon E. French | Chief Executive Officer, President & Director |
| Mr. David A. Lehman J.D. | General Counsel & Secretary |
| Dr. Derrick Sung Ph.D. | Chief Financial Officer & Chief Operating Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Steven S. Williamson | Advisor | Male | 1973 | 945.34K |
| Mr. Mehul Joshi | Advisor | Male | 1961 | 733.74K |
| Mr. Glendon E. French | Chief Executive Officer, President & Director | Male | 1962 | 717.22K |
| Mr. David A. Lehman J.D. | General Counsel & Secretary | Male | 1961 | 628.73K |
| Dr. Derrick Sung Ph.D. | Chief Financial Officer & Chief Operating Officer | 1973 | 358.06K |
Pulmonx Corporation Insider Trades
| Date | 3 Nov |
| Name | Sung Derrick |
| Role | COO and CFO |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 2 Sep |
| Name | Williamson Steven S. |
| Role | PRESIDENT AND CEO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 5118 |
| Date | 2 Sep |
| Name | Williamson Steven S. |
| Role | PRESIDENT AND CEO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 4530 |
| Date | 2 Sep |
| Name | Joshi Mehul |
| Role | Chief Financial Officer & PAO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 4271 |
| Date | 2 Sep |
| Name | Joshi Mehul |
| Role | Chief Financial Officer & PAO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 3665 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 3 Nov | Sung Derrick | COO and CFO | Disposed | 0 | |
| 2 Sep | Williamson Steven S. | PRESIDENT AND CEO | Disposed | S-Sale | 5118 |
| 2 Sep | Williamson Steven S. | PRESIDENT AND CEO | Disposed | S-Sale | 4530 |
| 2 Sep | Joshi Mehul | Chief Financial Officer & PAO | Disposed | S-Sale | 4271 |
| 2 Sep | Joshi Mehul | Chief Financial Officer & PAO | Disposed | S-Sale | 3665 |